NET LOSS PER SHARE - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
May 01, 2023 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Business Acquisition | ||||
| Antidilutive securities excluded from computation of earnings per share (in shares) | 1,546,358 | 693,448 | ||
| Medtech Concepts LLC | ||||
| Business Acquisition | ||||
| Stock based compensation capitalized | $ 4,500 | |||
| Stock based compensation service period (in years) | 4 years | |||
| Asset acquisition, contingent consideration cash consideration | $ 1,250 | |||
| Asset acquisition, contingent consideration (in shares) | 4,288,000 | |||
| Asset acquisition, contingent consideration, value | $ 133 | |||
| Anniversary payments | $ 3,861 | |||
| Asset acquisition, contingent consideration, liability, current | $ 1,368 | |||